Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ASCIMINIB Cause C-reactive protein increased? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of C-reactive protein increased have been filed in association with ASCIMINIB (SCEMBLIX). This represents 0.4% of all adverse event reports for ASCIMINIB.

9
Reports of C-reactive protein increased with ASCIMINIB
0.4%
of all ASCIMINIB reports
1
Deaths
5
Hospitalizations

How Dangerous Is C-reactive protein increased From ASCIMINIB?

Of the 9 reports, 1 (11.1%) resulted in death, 5 (55.6%) required hospitalization, and 2 (22.2%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ASCIMINIB. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does ASCIMINIB Cause?

Fatigue (193) Death (144) Nausea (138) Thrombocytopenia (125) Drug ineffective (117) Diarrhoea (103) Drug intolerance (98) Headache (91) Rash (86) Pleural effusion (75)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which ASCIMINIB Alternatives Have Lower C-reactive protein increased Risk?

ASCIMINIB vs ASCORBIC ACID ASCIMINIB vs ASCORBIC ACID\FERROUS ASCIMINIB vs ASCORBIC ACID\FERROUS\FOLIC ACID ASCIMINIB vs ASCORBIC ACID\POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM ASCORBATE\SODIUM\SODIUM ASCIMINIB vs ASENAPINE

Related Pages

ASCIMINIB Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased ASCIMINIB Demographics